Literature DB >> 8528594

Mast cell ontogeny and apoptosis.

D D Metcalfe1, J A Mekori, M Rottem.   

Abstract

The regulation of tissue mast cell number depends both on the rate of production of mast cell precursors from bone marrow and the length of survival of mature mast cells within tissues. Mast cells develop from bone marrow under the influence of both interleukin-3 (IL-3) and the c-kit ligand, also known as stem cell factor (SCF). In humans, the mast cell precursor is CD34+, FcERI-. Mast cell precursors with time become less responsive to IL-3 and more responsive to SCF. Mast cell proliferation directed by SCF is enhanced by other cytokines including both IL-4 and IL-10. Once mast cell precursors target to tissues, their survival may largely be dependent upon the local production of SCF. Withdrawal of IL-3 or SCF results in mast cell apoptosis; SCF rescues mast cells following IL-3 withdrawal. TGF-beta prevents this SCF rescue. Engagement of extracellular matrix by integrin receptors may also effect mast cell numbers. Thus, in the final analysis, mast cell numbers, while relatively constant in the normal state, may be up-regulated by altering the rate of their production centrally or length of survival in the periphery.

Entities:  

Mesh:

Year:  1995        PMID: 8528594     DOI: 10.1111/j.1600-0625.1995.tb00250.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  Age-related changes in dermal mast cell prevalence in BALB/c mice: functional importance and correlation with dermal mast cell expression of Kit.

Authors:  P H Hart; M A Grimbaldeston; E K Hosszu; G J Swift; F P Noonan; J J Finlay-Jones
Journal:  Immunology       Date:  1999-11       Impact factor: 7.397

2.  Multiple apoptotic defects in hematopoietic cells from mice lacking lipocalin 24p3.

Authors:  Zhuoming Liu; Amy Yang; Zhengqi Wang; Kevin D Bunting; Gangarao Davuluri; Michael R Green; Laxminarayana R Devireddy
Journal:  J Biol Chem       Date:  2011-04-20       Impact factor: 5.157

Review 3.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

Review 4.  Amplification mechanisms for the enhancement of antigen-mediated mast cell activation.

Authors:  Alasdair M Gilfillan; Richard D Peavy; Dean D Metcalfe
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 5.  Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Authors:  B M Jensen; C Akin; A M Gilfillan
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 6.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

7.  Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62.

Authors:  Dimity H Ball; Hwee Kee Tay; Kara S Bell; Michelle L Coates; Lamyaa Al-Riyami; Justyna Rzepecka; William Harnett; Margaret M Harnett
Journal:  J Parasitol Res       Date:  2013-02-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.